|
|
|
|
| Advertisement |
 |
|
|
|
|
| Advertisement |
 |
|
|
| Marketing |
 |
|
When One Brand is Not Enough |
In addition to the “new brand for new indication” approach, drug manufacturers have also re-launched a drug as a distinct second brand within the same indication. Ram Subramanian and Rehan Baqri lay out five objectives that make it worthwhile to pursue a second brand strategy
/Read more/ |
|
|
| US Election |
 |
|
Presidential Candidates & Rx Policy |
As the nation heads towards its first presidential primaries of the 2016 election, it’s important for American pharm execs to consider where the leading candidates stand on U.S. Rx policy. Tom Norton takes a closer look
/Read more/ |
|
|
|
| Industry update |
| //Affimed (Heidelberg, Germany) appointed Dr. Joerg Windisch as Chief Operating Officer.//Kantar Health (New York, NY) announced that Stephen Potts has been named Managing Director of Kantar Health UK.//Agios Pharmaceuticals (Cambridge, UK) appointed Steve Hoerter to the newly created position of Chief Commercial Officer, effective February 16, 2016.//Crescendo Biologics Limited (Cambridge, UK) appointed Dr. Barbara Fleck as Head of Intellectual Property.// |
|
|
| |
|
|
